Longitudinal Analysis Evaluating Self-Reported CPAP Use for OSA during the COVID-19 Pandemic.

Abstract

Continuous positive airway pressure therapy (CPAP) is a highly effective treatment for obstructive sleep apnea (OSA), but CPAP adherence remains suboptimal. The COVID-19 pandemic significantly altered sleep medicine services and aspects of daily living for sleep medicine patients, which may further compromise CPAP adherence. Sleep medicine patients were distributed an online survey at baseline and six months later (January-May 2021). Participants answered questions regarding CPAP use (any changes in CPAP use, sleep quality with CPAP use, CPAP use as advised, and changes in daily habits). Eighty-one adults completed the baseline survey, and 54 adults completed the follow-up survey. Twenty-seven participants reported a diagnosis of OSA and were prescribed CPAP (mean age 58 ± 18.2 years, 48% female, 67% Caucasian). Longitudinal analysis with chi-square association testing showed significant changes in CPAP use as advised and significant improvements in sleep quality with CPAP use when comparing the baseline to six-month follow-up survey. Additionally, logistic regression was performed to determine if pre-pandemic sleep study results (apnea-hypopnea index and respiratory disturbance index) predicted self-reported CPAP use during the pandemic, though no association was found. Throughout the pandemic, sleep medicine patients improved their CPAP use as advised and reported significant improvements in sleep quality with CPAP use.

• Authors: Taylor Torrence Teague, Ahmad Debian, Manasa Kokonda, Sonal Malhotra, Emily Arentson-Lantz, Fidaa Shaib, Sara Nowakowski
• Journal: Brain sciences (Brain Sci) Vol. 12 Issue 2 (Jan 19 2022) ISSN: 2076-3425 [Print] Switzerland
• PMID: 35203895 (Publication Type: Journal Article)